FDA Approved: DALFAMPRIDINE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

The FDA approved a supplemental application for dalfampridine from Micro Labs Limited (ANDA210158), enabling a generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)